NDC codes

FDA NDC Directory
Product NDC (as listed)70771-1797Labeler and product segments. Claims need a package NDC.
Product NDC at billing width70771-1797Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
70771-1797-67077117970660 TABLET, FILM COATED in 1 BOTTLE (70771-1797-6)Marketed from Feb 14, 2025 · Sample package

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Selexipag
Generic name (nonproprietary)
selexipag
Active ingredients
Selexipag — 1000 ug/1
Dosage form
Tablet, Film coated
Route
Oral
Labeler
Zydus Lifesciences LimitedNDC labeler code 70771
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 214302
Marketing start
Listing expires
Other FDA classes
Prostacyclin Receptor Agonists (Mechanism)
Identifiers
Product ID 70771-1797_e39f2aba-4f8f-49d0-82e2-ee509b830d36SPL ID e39f2aba-4f8f-49d0-82e2-ee509b830d36SPL set ID ff660787-880f-4f2b-baac-fd2dbfcd79c2RxCUI 1729007, 1729027, 1729031, 1729045, 1729051, 1729055, 1729059, 1729063, 1729075UNII 5EXC0E384LUPC 0370771179763, 0370771179466, 0370771180066, 0370771179664, 0370771179862, 0370771179565, 0370771179367, 0370771179961
Pharmacologic class
Prostacyclin Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470771179706 followed by a unit qualifier and the quantity

Package 70771-1797-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

Selexipag tablets are a prostacyclin receptor agonist indicated for the treatment of pulmonary arterial hypertension (PAH, WHO Group I) to delay disease progression and reduce the risk of hospitalization for PAH. ( 1.1 ) 1.1 Pulmonary Arterial Hypertension Selexipag tablets are indicated for the treatment of pulmonary arterial hypertension (PAH, WHO Group I) to delay disease progression and reduce the risk of hospitalization for PAH. Effectiveness of selexipag tablets was established in a long-term study in PAH patients with WHO Functional Class II-III symptoms. Patients had idiopathic and heritable PAH (58%), PAH associated with connective tissue disease (29%), PAH associated with congenita…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70771-1797

What is NDC 70771-1797?
70771-1797 is the product NDC for Selexipag, Selexipag 1000 ug/1 tablet, film coated, listed with the FDA by Zydus Lifesciences Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Selexipag.
What is the active ingredient?
Selexipag.
Who is the labeler?
Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Selexipag?
15 other product NDCs are listed under this name. See all Selexipag NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Selexipag NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
SelexipagSelexipag 600 ug/1Tablet, Film coatedOralZydus Lifesciences Limited70771-179570771-1795-06
SelexipagSelexipag 200 ug/1Tablet, Film coatedOralZydus Lifesciences Limited70771-179370771-1793-0670771-1793-08
SelexipagSelexipag 400 ug/1Tablet, Film coatedOralZydus Lifesciences Limited70771-179470771-1794-06
SelexipagSelexipag 800 ug/1Tablet, Film coatedOralZydus Lifesciences Limited70771-179670771-1796-06
SelexipagSelexipag 1200 ug/1Tablet, Film coatedOralZydus Lifesciences Limited70771-179870771-1798-06
SelexipagSelexipag 1400 ug/1Tablet, Film coatedOralZydus Lifesciences Limited70771-179970771-1799-06
SelexipagSelexipag 400 ug/1Tablet, Film coatedOralZydus Pharmaceuticals (USA) Inc.70710-155270710-1552-06
SelexipagSelexipag 1600 ug/1Tablet, Film coatedOralZydus Lifesciences Limited70771-180070771-1800-06
SelexipagSelexipag 200 ug/1Tablet, Film coatedOralZydus Pharmaceuticals (USA) Inc.70710-155170710-1551-0670710-1551-08
SelexipagSelexipag 600 ug/1Tablet, Film coatedOralZydus Pharmaceuticals (USA) Inc.70710-155370710-1553-06

All 16 Selexipag NDCs

Other NDCs under ANDA 214302

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214302
ProductStrengthForm · routeLabelerProduct NDC
Selexipag TITRATION PACKselexipag—KitZydus Pharmaceuticals (USA) Inc.70710-1653
SelexipagSelexipag 600 ug/1Tablet, Film coatedOralZydus Lifesciences Limited70771-1795
SelexipagSelexipag 200 ug/1Tablet, Film coatedOralZydus Lifesciences Limited70771-1793
SelexipagSelexipag 400 ug/1Tablet, Film coatedOralZydus Lifesciences Limited70771-1794
SelexipagSelexipag 800 ug/1Tablet, Film coatedOralZydus Lifesciences Limited70771-1796
SelexipagSelexipag 1200 ug/1Tablet, Film coatedOralZydus Lifesciences Limited70771-1798
SelexipagSelexipag 1400 ug/1Tablet, Film coatedOralZydus Lifesciences Limited70771-1799
SelexipagSelexipag 400 ug/1Tablet, Film coatedOralZydus Pharmaceuticals (USA) Inc.70710-1552
SelexipagSelexipag 1600 ug/1Tablet, Film coatedOralZydus Lifesciences Limited70771-1800
SelexipagSelexipag 200 ug/1Tablet, Film coatedOralZydus Pharmaceuticals (USA) Inc.70710-1551
Selexipag TITRATION PACKselexipag—KitZydus Lifesciences Limited70771-1801
SelexipagSelexipag 600 ug/1Tablet, Film coatedOralZydus Pharmaceuticals (USA) Inc.70710-1553
SelexipagSelexipag 1200 ug/1Tablet, Film coatedOralZydus Pharmaceuticals (USA) Inc.70710-1556
SelexipagSelexipag 800 ug/1Tablet, Film coatedOralZydus Pharmaceuticals (USA) Inc.70710-1554
SelexipagSelexipag 1000 ug/1Tablet, Film coatedOralZydus Pharmaceuticals (USA) Inc.70710-1555
SelexipagSelexipag 1400 ug/1Tablet, Film coatedOralZydus Pharmaceuticals (USA) Inc.70710-1557
SelexipagSelexipag 1600 ug/1Tablet, Film coatedOralZydus Pharmaceuticals (USA) Inc.70710-1558

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in